Title |
HINT1 neuropathy in Lithuania: clinical, genetic, and functional profiling / |
Authors |
Malcorps, Matilde ; Amor-Barris, Silvia ; Burnytė, Birutė ; Vilimienė, Ramunė ; Armirola‑Ricaurte, Camila ; Grigalionienė, Kristina ; Morkūnienė, Aušra ; Vaitkevičius, Arūnas ; De Vriendt, Els ; Baets, Jonathan ; Scherer, Steven S ; Ambrozaitytė, Laima ; Utkus, Algirdas ; Jordanova, Albena ; Peeters, Kristien |
DOI |
10.1186/s13023-022-02541-0 |
Full Text |
|
Is Part of |
Orphanet journal of rare diseases.. London : BMC. 2022, vol. 17, iss. 1, art. no. 374, p. [1-11].. eISSN 1750-1172 |
Keywords [eng] |
Peripheral neuropathy ; Charcot-Marie-Tooth disease ; HINT1 ; Neuromyotonia, Lithuania |
Abstract [eng] |
Background Recessive loss-of-function variations in HINT1 cause a peculiar subtype of Charcot-Marie-Tooth disease: neuromyotonia and axonal neuropathy (NMAN; OMIM[#137200]). With 25 causal variants identified worldwide, HINT1 mutations are among the most common causes of recessive neuropathy. The majority of patients are compound heterozygous or homozygous for a Slavic founder variant (c.110G>C, p.Arg37Pro) that has spread throughout Eurasia and America. Results In a cohort of 46 genetically unresolved Lithuanian patients with suspected inherited neuropathy, we identified eight families with HINT1 biallelic variations. Most patients displayed sensorimotor or motor-predominant axonal polyneuropathy and were homozygous for the p.Arg37Pro variant. However, in three families we identified a novel variant (c.299A>G, p.Glu100Gly). The same variant was also found in an American patient with distal hereditary motor neuropathy in compound heterozygous state (p.Arg37Pro/p.Glu100Gly). Haplotype analysis demonstrated a shared chromosomal region of 1.9 Mb between all p.Glu100Gly carriers, suggesting a founder effect. Functional characterization showed that the p.Glu100Gly variant renders a catalytically active enzyme, yet highly unstable in patient cells, thus supporting a loss-of-function mechanism. Conclusion Our findings broaden NMAN's genetic epidemiology and have implications for the molecular diagnostics of inherited neuropathies in the Baltic region and beyond. Moreover, we provide mechanistic insights allowing patient stratification for future treatment strategies. |
Published |
London : BMC |
Type |
Journal article |
Language |
English |
Publication date |
2022 |
CC license |
|